These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6527814)

  • 41. Timely detection: key to optimal management of breast cancer.
    Ginsberg SJ
    Geriatrics; 1982 Jan; 37(1):97-106. PubMed ID: 7054059
    [No Abstract]   [Full Text] [Related]  

  • 42. Breast cancer management in the nineteen nineties.
    Cummings FJ; Glicksman AS; Wanebo HJ
    R I Med; 1992 Jan; 75(1):21-9. PubMed ID: 1543888
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prognostic factors in breast cancer and recurrence: study using a quantification theory; type-II].
    Murayama Y; Ogiwara H
    Gan No Rinsho; 1984 Apr; 30(4):353-6. PubMed ID: 6727036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
    ; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
    J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapeutic update on cancer of the breast].
    Awada A; Leo AD; Piccart MJ
    Bull Cancer; 2000 Jan; 87(1):49-62. PubMed ID: 10673632
    [No Abstract]   [Full Text] [Related]  

  • 46. Evolution of knowledge related to breast cancer heterogeneity: a 25-year retrospective.
    Fisher B; Redmond CK; Fisher ER
    J Clin Oncol; 2008 May; 26(13):2068-71. PubMed ID: 18445835
    [No Abstract]   [Full Text] [Related]  

  • 47. [Breast cancer in young women. Does it have special diagnostic, therapeutic and prognostic factors?].
    Body G
    Rev Fr Gynecol Obstet; 1994 Nov; 89(11):570-2. PubMed ID: 7817087
    [No Abstract]   [Full Text] [Related]  

  • 48. The Auckland Breast Cancer Register: a special project of the Auckland Breast Cancer Study Group.
    Neave L; Harvey V; Benjamin C; Thompson P; Pellett O; Whitlock J; Jones W; Poole G;
    N Z Med J; 2003 Oct; 116(1184):U648. PubMed ID: 14583806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time to stop progesterone receptor testing in breast cancer management.
    Olivotto IA; Truong PT; Speers CH; Bernstein V; Allan SJ; Kelly SJ; Lesperance ML
    J Clin Oncol; 2004 May; 22(9):1769-70. PubMed ID: 15118010
    [No Abstract]   [Full Text] [Related]  

  • 50. [Breast cancer recurrences and metastases].
    Bazhenova AP; Kachanov IP
    Khirurgiia (Mosk); 1980 Apr; (4):7-12. PubMed ID: 7374084
    [No Abstract]   [Full Text] [Related]  

  • 51. Cancer of the breast: the past decade (first of two parts).
    Henderson IC; Canellos GP
    N Engl J Med; 1980 Jan; 302(1):17-30. PubMed ID: 6985698
    [No Abstract]   [Full Text] [Related]  

  • 52. Locally advanced and inflammatory breast cancer.
    Ahern V; Brennan M; Ung O; Kefford R
    Aust Fam Physician; 2005 Dec; 34(12):1027-32. PubMed ID: 16333485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of the therapy combined with oophorectomy for the advanced breast cancer].
    Shinoda M; Oka T
    Gan No Rinsho; 1971; 17(9):670-5. PubMed ID: 5165861
    [No Abstract]   [Full Text] [Related]  

  • 55. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy.
    Low JA; Berman AW; Steinberg SM; Danforth DN; Lippman ME; Swain SM
    J Clin Oncol; 2004 Oct; 22(20):4067-74. PubMed ID: 15483018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re-evaluation of prognostic mitotic figure counting in breast cancer: results of a prospective clinical follow-up study.
    Biesterfeld S; Reitmaier M
    Anticancer Res; 2001; 21(1B):589-94. PubMed ID: 11299810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cancer of the breast in males].
    Nagel M; Holtkamp B; Hagmuller E; Saeger HD
    J Chir (Paris); 1993; 130(6-7):300-3. PubMed ID: 8408331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diagnosis and treatment of breast cancer].
    Takenaka A; Fujii K
    Kurinikaru Sutadi; 1986 Aug; 7(8):853-8. PubMed ID: 3640169
    [No Abstract]   [Full Text] [Related]  

  • 60. [Inflammatory breast cancer: clinical course, diagnosis and treatment].
    Borisov VI; Chkhikvadze TV
    Vopr Onkol; 2008; 54(1):86-9. PubMed ID: 18416065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.